ARYx Therapeutics Schedules Fourth Quarter and Year End 2008 Results and Earnings Call.FREMONT, Calif. -- ARYx Therapeutics, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ARYX), a biopharmaceutical company, announced today that a conference call to discuss fourth quarter and year end 2008 results will be held on Thursday, March 26, 2009 at 8:00 a.m. Pacific Time. The dial-in information for the call is as follows: Dial In (Toll Free): 877-874-1589 Dial In (International): 719-325-4805 Passcode (if requested): 6454631 Preregistration pre·reg·is·tra·tion n. An early registration, as for returning college students, that takes place before general registration. is not required. This call is also being webcast and can be accessed at ARYx Therapeutics' web site at www.aryx.com. Replays of the call will be available through May 1, 2009 at the ARYx web site. About ARYx Therapeutics, Inc. ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered products designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of these original drugs but are metabolized through a potentially safer pathway to avoid specific adverse side effects Side effects Effects of a proposed project on other parts of the firm. associated with these compounds. ARYx currently has four products in clinical trials: an oral anticoagulant anticoagulant (ăn'tēkōăg`yələnt), any of several substances that inhibit blood clot formation (see blood clotting). agent for patients at risk for the formation of dangerous blood clots Blood Clots Definition A blood clot is a thickened mass in the blood formed by tiny substances called platelets. Clots form to stop bleeding, such as at the site of cut. , tecarfarin (previously ATI-5923); an oral anti-arrhythmic agent for the treatment of atrial fibrillation, budiodarone (previously ATI-2042); a prokinetic agent for the treatment of various gastrointestinal disorders, ATI-7505; and, an agent for the treatment of schizophrenia The concept of a cure as such in the treatment of schizophrenia remains controversial, as there is no consensus on the definition of "treatment" in the case of schizophrenia, although some criteria for the remission of symptoms have recently been suggested. and other psychiatric disorders, ATI-9242. Please visit our web site at www.aryx.com for additional information. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion